-
Report details
-
17
Figures
-
4
Tables
-
Market Analysis: POC COVID-19 Testing
-
Overview of POC COVID-19 Testing
-
Market Outlook
-
Setting Market
-
Top Company Briefs
-
Abbott
-
Roche
-
Quidel
-
Becton Dickinson
-
Executive News Briefing
-
Pathware Appoints New CEO
-
Mainz Biomed Appoints New COO
-
Personalis Appoints New VP of Diagnostic Sales
-
Financial Highlights: bioMérieux, Guardant Health, Lucira Health
-
bioMérieux Full-Year Sales up 10.5% in 2021 Like-for-Like
-
Guardant Reports Growth in Clinical (+38.5%) and Biopharma (+16.5%) Test Volumes
-
Lucira Health Reports First Full Year of Commercialization
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Partnerships and Collaborations
-
Mergers and Acquisitions
-
Industry Watch
-
Region Watch
-
Broad-based Company Announcements
-
Biomerica Submitted H. pylori Test to FDA
-
Bruker Launches New LiquidArray Multiplex PCR Assays
-
C2i Genomics Launched MRD Test in Europe
|
In Vitro Diagnostics Business Outlook: Volume 1, Issue 14
9 May 2022
A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Page Count: 39
Table of Contents
-
Market Analysis: POC COVID-19 Testing
-
Overview of POC COVID-19 Testing
-
Market Outlook
-
Setting Market
-
Top Company Briefs
-
Abbott
-
Roche
-
Quidel
-
Becton Dickinson
-
Executive News Briefing
-
Pathware Appoints New CEO
-
Mainz Biomed Appoints New COO
-
Personalis Appoints New VP of Diagnostic Sales
-
Financial Highlights: bioMérieux, Guardant Health, Lucira Health
-
bioMérieux Full-Year Sales up 10.5% in 2021 Like-for-Like
-
Guardant Reports Growth in Clinical (+38.5%) and Biopharma (+16.5%) Test Volumes
-
Lucira Health Reports First Full Year of Commercialization
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Partnerships and Collaborations
-
Mergers and Acquisitions
-
Industry Watch
-
Region Watch
-
Broad-based Company Announcements
-
Biomerica Submitted H. pylori Test to FDA
-
Bruker Launches New LiquidArray Multiplex PCR Assays
-
C2i Genomics Launched MRD Test in Europe
|
More information about this product
Other Users Also Viewed
5 May 2022
Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027 focuses on the market for single cell genomics products -- the hardware, service of the hardware, software, and…
|
